At Arab Health 2023 in Dubai, G42 Healthcare, the premier AI health-tech firm with headquarters in Abu Dhabi, and Mubadala Health, an integrated network of top-notch healthcare facilities, will take centre stage to present their cutting-edge treatments and patient care. A new age of rapid transformation for the area and beyond is about to begin as a result of the cooperation between these two top healthcare organisations. It is intended to alter the regional healthcare system and introduce a new method of providing individualised, patient-centered care.
In order to build a brand-new, first-of-its-kind integrated healthcare firm that integrates G42 Healthcare’s distinctive medical and data-centric technology with Mubadala Health’s top-tier care delivery, Mubadala Health and G42 Healthcare announced their merger in October 2022. To help healthcare stakeholders, including policy drivers, thought leaders, professionals, and decision-makers, stay on top of the latest developments, Mubadala Health and G42 Healthcare, two Gold Sponsors, will be showcasing their AI-powered solutions in diagnostics, digital health, therapeutics, advanced omics, and patient care at Arab Health, the largest healthcare event in the Middle East.
G42 Healthcare is utilising its strengths and expertise through its participation under the theme of Arab Health 2023 – “How Are You Doing, Tomorrow?” to showcase solutions that unlock healthcare intelligence and facilitate global expansion to help address the most pressing healthcare challenges in the world. The network’s best-in-class integrated and multidisciplinary care will continue to be built upon as Mubadala Health makes announcements during the event about its plans to expand geographically. This includes facilities like Mubadala Health Dubai, which assembles a western-board certified medical team from its existing network of top-notch healthcare partners to offer residents of the UAE and the greater region closer to home an international standard and continuum of care at every stage of life.
Hasan Jasem Al Nowais, chief executive officer of Mubadala Health and CEO of the newly merged entity, said: “Our participation with G42 Healthcare at Arab Health 2023 is an opportunity to showcase our unity and willingness to introduce to the market innovative solutions through collaboration. Together, we are looking to apply health-tech solutions to elevate our standards of accessible, patient-centered and specialized healthcare services, like never before. In line with the directives of the UAE’s wise leadership, our merger is pioneering healthcare technologies and methods so that we can be better prepared and equipped to effectively manage healthcare challenges in the future, while continuing our wider efforts to reduce the prevalence of lifestyle diseases related to diabetes, heart disease, obesity, and cancer, amongst others.” According to the Zawya, echoing this theme, Mubadala Health speakers will be participating on various panels including: “The Growing Role of Technology in Healthcare: Abu Dhabi’s Healthcare Transformation”, as well as “Sustainability in the Healthcare Sector from an Environmental and Human Perspective” with panellists from Emirates Health Services and Local/International Hospital.
Ashish Koshy, chief executive officer of G42 Healthcare, said: “G42 Healthcare is pleased to be the Gold Sponsor at Arab Health, where we showcase our strengths to facilitate global healthcare growth. Our multi-omics, health-tech, CRO, diagnostics and biobanking services make us the partner of choice for countries and corporations to enable healthcare transformations. We are excited at the possibilities of shaping tomorrow with entities that share our values and vision, as we partner with governments, policymakers, scientists, academia, research organizations and the larger medical community to invent better healthcare every day.”
